- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 14, 2025 | 6.18M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $10.61M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $11.98M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $23.31M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $23.47M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $78.33M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $79.75M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $58.52M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $61.61M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $154.94M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $162.34M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 5.87M sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 5.86M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $217K |
| Capex | Q3 2025 · Mar 31, 2024 | $1.98M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $1.22M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $84.1M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $85.46M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $88.77M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.27 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.91 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.27 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.91 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $3.87M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $11.46M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$1.58M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$5.34M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$1.95M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$6.01M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $1.92M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $5.45M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $23.21M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $78.86M |